statin discontinuation. In a recent series ofstudies, a novel autoantibody specificity recognizing anautoantigenmigrating as a doublet of 100k/200k bands was defined in a group of immunosuppression-responsive patients with a necrotizing myopathy and very high CK levels (Christopher-Stine et al., 2010...
high cholesterol or other factors that put them at higher risk for heart issues, Dr. Tracy said, adding, "Patients who have familialhigh cholesterolor those who have an LDL cholesterol greater than 160 and have not had a heart attack would be examples." ...
61 This code for a concussion diagnosis has been validated with high specificity (99%) and moderate sensitivity (46%-76%).62,63 Patients who were admitted to a hospital within 2 days of a concussion or who survived less than 90 days were excluded to reduce confounding from severe brain ...
Treatment with high-intensity statins, such as atorvastatin 20 mg upwards, results in a 36% proportional increase in new type 2 diabetes diagnoses com...
Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary ...
“The connection of statins with diabetes is a bit stronger," Tracy said. “But for those patients that we have on statins, we have to do the risk versus benefit for the very low chance of developing diabetes and the high positive benefit on their coronary or cerebral circulation.” ...
(Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) [156]. The JUPITER trial revealed that even patients with no documented CVD and normal LDL-C (<3.4 mmol/L = 130 mg/dL) but with elevated levels of high-sensitivity C-reactive protein (CRP) ...
RESEARCH Statin use and risk of community acquired pneumonia in older people: population based case-control study Sascha Dublin, assistant investigator,1,2 Michael L Jackson, EIS officer,1 Jennifer C Nelson, associate investigator,1,3 Noel S Weiss, professor,2 Eric B Lars...
Background: Recent analyses have challenged the benefit of statin and aspirin therapy for primary prevention in patients at high cardiovascular risk. Equally uncertain is the optimal therapy for patients with non-obstructive coronary ath... B. Chow,G. Small,S Achenbach,... - 《Circulation》 被引...
Clinically stable patients who underwent DES implantation 12 months previously and received aspirin monotherapy were randomly assigned to receive either high-intensity (40mg atorvastatin, n = 1000) or low-intensity (20mg pravastatin, n = 1000) statin treatment. The primary endpoint was adverse clinical...